ARWR
Arrowhead Pharmaceuticals Inc
NASDAQ: ARWR · HEALTHCARE · BIOTECHNOLOGY
$73.48
+4.18% today
Updated 2026-04-30
Market cap
$9.88B
P/E ratio
44.08
P/S ratio
9.05x
EPS (TTM)
$1.60
Dividend yield
—
52W range
$12 – $77
Volume
2.2M
Arrowhead Pharmaceuticals Inc (ARWR) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-14.79M | $-23.87M | $-27.58M | $-15.28M | $-7.70M | $-5.39M | $-15.34M | $-19.03M | $-35.42M | $-65.71M | $-64.43M | $-23.94M | $-47.22M | $173.03M | $-95.80M | $171.31M | $-136.13M | $-153.89M | $-462.85M | $179.55M |
| Capital expenditures | $934517.00 | $756371.00 | $684111.00 | $40245.00 | $5407.00 | $9674.00 | $479710.00 | $296880.00 | $1.72M | $1.97M | $3.86M | $7.92M | $1.42M | $12.00M | $11.95M | $23.57M | $52.78M | $176.74M | $141.47M | $22.67M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $1.37B | — | — | $2.68M | $1.42M | $1.38M | $1.24M | $1.54M | $5.70M | $10.23M | $11.60M | $7.89M | $8.45M | $12.39M | $43.38M | $76.67M | $120.89M | $78.13M | $73.97M | $63.37M |
| Free cash flow | $-15.73M | $-24.62M | $-28.27M | $-15.32M | $-7.70M | $-5.40M | $-15.82M | $-19.33M | $-37.13M | $-67.68M | $-68.29M | $-31.86M | $-48.64M | $161.03M | $-107.75M | $147.75M | $-188.91M | $-330.63M | $-604.32M | $156.89M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | $660227.00 | $-4.13M | $15.74M | $113.40M | $-51.30M | $4.15M | $-60.53M | $5.29M | — | $-78.22M | $40.85M | $-76.36M | — | — | — |